查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429402

2024 年给药装置全球市场报告

Drug Delivery Devices Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

药物输送设备的市场规模预计在未来几年将显着成长。预计到 2028 年将以 6.6% 的复合年增长率 (CAGR) 增长至 1,220.7 亿美元。未来一段时间的预期扩张将是由于慢性病盛行率上升、注射药物需求增加、给药装置需求增加以及严重感染疾病突然出现等原因。预测期内预期的主要趋势包括对用于给药的微针给药技术的投资、自行注射给药装置的研发、重点併购以及对可穿戴给药装置的投资等都包括在内。

心血管疾病、糖尿病、癌症和其他疾病等慢性疾病的盛行率不断上升，预计将推动药物传输设备市场的发展。例如，根据国家医学图书馆 2023 年 1 月的数据，美国50 岁及以上患有至少一种慢性疾病的人数预计将增加 99.5%，到 2050 年达到 1.4266 亿。给药途径有多种，选择取决于三个因素：所需效果、疾病类型和产品类型。由于慢性病盛行率不断上升，製药业目前正专注于开发新的药物输送系统，全球加强了研发。许多製药公司都专注于多种药物传输技术，以增强其产品的功效并改善结果。因此，慢性病盛行率的不断上升导致治疗药物和疗法的消费量增加，从而推动了药物输送设备市场的成长。

生技药品需求的增加预计将有助于药物输送设备市场的扩大。生技药品，也称为生技药品或生物製药，是利用活生物体、细胞或生物过程开发的药物。生技药品递送装置透过改善递送方法、提供非侵入性递送、保护货物、提供控制释放、实现标靶递送以及提供先进的药物递送系统，在增强生物製剂的递送方面发挥着重要作用。据加拿大政府称，2023年6月，以2021年人均支出计算，加拿大在经济合作暨发展组织（OECD）国家中名列前茅，生技药品销售额超过110亿美元。因此，对生技药品的需求不断增长正在推动药物传输设备市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球给药器械市场的驱动和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球给药装置市场规模、表现与成长
  • 2023-2028、2033年全球给药装置市场规模及成长预测

第六章市场区隔

  • 全球给药装置市场，依给药途径细分、绩效与预测，2018-2023、2023-2028、2033
  • 口服给药
  • 注射给药
  • 局部给药
  • 经眼给药
  • 肺部药物输送
  • 鼻腔给药
  • 粘膜给药
  • 植入式药物输送
  • 全球给药设备市场，依患者照护地点、绩效及预测细分，2018-2023、2023-2028、2033
  • 医院
  • 诊断中心
  • 门诊手术中心/诊所
  • 居家医疗
  • 其他的
  • 全球给药装置市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 癌症
  • 感染疾病
  • 呼吸系统疾病
  • 糖尿病
  • 心血管疾病
  • 自体免疫疾病
  • 中枢神经系统疾病
  • 其他的

第 7 章 区域与国家分析

  • 全球药物传输设备市场，按地区、绩效及预测，2018-2023年、2023-2028年、2033年
  • 全球药物传输设备市场，依国家、绩效及预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 给药装置市场竞争形势
  • 药物传输设备市场公司概况
    • Becton, Dickinson and Company
    • Baxter International
    • B. Braun Melsungen AG
    • Catalent
    • 3M Company

第31章 其他大型创新公司

  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Smiths Medical
  • Boehringer Ingelheim
  • SMC Ltd.
  • Elcam Medical
  • Eli Lilly and Company
  • Gerresheimer
  • Injex
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc
  • Sanofi Sa
  • Schott AG
  • Terumo Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与潜力分析

第36章附录

简介目录
Product Code: r14414

Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.

The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.

The drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery devices market size has grown strongly in recent years. It will grow from $87.65 billion in 2023 to $94.7 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The expansion observed in the past can be credited to the swift increase in the elderly population, a rise in the number of healthcare facilities, economic growth in emerging markets, and an augmentation in healthcare expenditure.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $122.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated expansion in the upcoming period can be ascribed to the rising prevalence of chronic diseases, growing demand for injectables, an increasing need for drug delivery devices, and the sudden emergence of severe infections. Key trends expected in the forecast period involve investments in microneedle drug technology for drug delivery, the research and development of self-injectable drug delivery devices, a focus on mergers and acquisitions, and investments in wearable drug delivery devices.

The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, and other conditions is expected to propel the drug delivery devices market. For example, in January 2023, according to the National Library of Medicine, the number of individuals in the United States aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Various routes of drug administration exist, and the choice depends on three factors, the desired effect, the type of disease, and the product type. The pharmaceutical industry is currently emphasizing the development of new drug delivery systems, driven by increasing R&D efforts worldwide due to the rising prevalence of chronic diseases. Many pharmaceutical companies are concentrating on multiple drug delivery technologies to enhance advantages and improve outcomes for their products. Therefore, the growing prevalence of chronic diseases is leading to increased consumption of therapeutic drugs and therapies, acting as a driver for the drug delivery devices market's growth.

The increasing demand for biologics is expected to contribute to the expansion of the drug delivery device market. Biologics, also known as biologic products or biopharmaceuticals, are pharmaceuticals developed using living organisms, cells, or biological processes. Drug delivery devices play a crucial role in enhancing biologics delivery by improving delivery methods, providing non-invasive delivery, protecting cargo, offering controlled release, enabling targeted delivery, and providing advanced drug delivery systems. In June 2023, according to the Government of Canada, Canada ranked among the top nations in the Organization for Economic Co-operation and Development (OECD) in terms of per capita spending in 2021, with biologics sales exceeding $11 billion. Hence, the increasing demand for biologics is a driving force for the growth of the drug delivery device market.

Leading companies in the drug delivery device market are strategically focusing on the development of innovative devices, such as autoinjectors with fully integrated connectivity, to gain a competitive advantage. Autoinjectors are specialized medical devices designed for self-administration of pre-measured medication doses. For example, in December 2021, Ypsomed AG, a Switzerland-based manufacturer of injection and infusion equipment, introduced YpsoMate, an autoinjector featuring fully integrated connectivity. The device is equipped with standard built-in Bluetooth communication, enabling connectivity to mobile phones and tablets for the transfer of injection and device data. This autoinjector provides digital therapy support by automatically recording medication administrations and sharing data with healthcare providers.

Microneedle (MN) technology is recognized for its efficiency and versatility in the medical device landscape, boasting attributes such as painless penetration, cost-effectiveness, high therapeutic efficacy, and relative safety. Key players in the global microneedle drug delivery system market include 3M, Vetter Pharma International GmbH, Nano Biosciences LLC, Nano Pass, and others. Microneedles are crafted using biodegradable polymers that encapsulate drugs or vaccines. Upon dissolution in the skin, the microneedles release the drug. This innovative delivery method facilitates the passage of a diverse range of molecules through the skin barrier, allowing transdermal delivery for various clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition aligns with Sandoz's strategic goal of expanding its current respiratory medication portfolio and enhancing patient access to advanced treatments. Coalesce Product Development Limited, based in the UK, specializes in the manufacturing of respiratory medical and medication delivery devices.

Major companies operating in the drug delivery devices market report are Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Gerresheimer, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, West Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc., Covidien plc

North America was the largest region in the drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Tapered Implants; Parallel Walled Implants
  • 2) By Material: Titanium; Zirconium; Other Materials
  • 3) By End-Use: Hospitals; Dental Clinics; Other End Uses
  • Companies Mentioned: Becton, Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; 3M Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Delivery Devices Market Characteristics

3. Drug Delivery Devices Market Trends And Strategies

4. Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Delivery Devices Market Size and Growth

  • 5.1. Global Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Delivery Devices Market Segmentation

  • 6.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
  • 6.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Other Patient Care Settings
  • 6.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Other Applications

7. Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Delivery Devices Market

  • 8.1. Asia-Pacific Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Delivery Devices Market

  • 9.1. China Drug Delivery Devices Market Overview
  • 9.2. China Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Delivery Devices Market

  • 10.1. India Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Delivery Devices Market

  • 11.1. Japan Drug Delivery Devices Market Overview
  • 11.2. Japan Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Delivery Devices Market

  • 12.1. Australia Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Delivery Devices Market

  • 13.1. Indonesia Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Delivery Devices Market

  • 14.1. South Korea Drug Delivery Devices Market Overview
  • 14.2. South Korea Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Delivery Devices Market

  • 15.1. Western Europe Drug Delivery Devices Market Overview
  • 15.2. Western Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Delivery Devices Market

  • 16.1. UK Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Delivery Devices Market

  • 17.1. Germany Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Delivery Devices Market

  • 18.1. France Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Delivery Devices Market

  • 19.1. Italy Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Delivery Devices Market

  • 20.1. Spain Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Delivery Devices Market

  • 21.1. Eastern Europe Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Delivery Devices Market

  • 22.1. Russia Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Delivery Devices Market

  • 23.1. North America Drug Delivery Devices Market Overview
  • 23.2. North America Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Delivery Devices Market

  • 24.1. USA Drug Delivery Devices Market Overview
  • 24.2. USA Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Delivery Devices Market

  • 25.1. Canada Drug Delivery Devices Market Overview
  • 25.2. Canada Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Delivery Devices Market

  • 26.1. South America Drug Delivery Devices Market Overview
  • 26.2. South America Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Delivery Devices Market

  • 27.1. Brazil Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Delivery Devices Market

  • 28.1. Middle East Drug Delivery Devices Market Overview
  • 28.2. Middle East Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Delivery Devices Market

  • 29.1. Africa Drug Delivery Devices Market Overview
  • 29.2. Africa Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Drug Delivery Devices Market Competitive Landscape
  • 30.2. Drug Delivery Devices Market Company Profiles
    • 30.2.1. Becton, Dickinson and Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Baxter International
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. B. Braun Melsungen AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Catalent
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. 3M Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. West Pharmaceutical Services, Inc.
  • 31.2. Gerresheimer AG
  • 31.3. Smiths Medical
  • 31.4. Boehringer Ingelheim
  • 31.5. SMC Ltd.
  • 31.6. Elcam Medical
  • 31.7. Eli Lilly and Company
  • 31.8. Gerresheimer
  • 31.9. Injex
  • 31.10. Novartis AG
  • 31.11. Novo Nordisk A/S
  • 31.12. Pfizer Inc
  • 31.13. Sanofi Sa
  • 31.14. Schott AG
  • 31.15. Terumo Corporation

32. Global Drug Delivery Devices Market Competitive Benchmarking

33. Global Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Delivery Devices Market

35. Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer